Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP

Highlights Purkinje cell excitability dramatically increased after exposure to 3-AP. 3-AP caused a significant decrease in ISI, half-width, and first spike latency. CB1R antagonist attenuated the cellular effects of 3-AP. AM251 reduced the excitability of Purkinje cells exposed to 3-AP.

Bibliographic Details
Main Authors: Hoda Ranjbar, Monavareh Soti, Kristi A. Kohlmeier, Mahyar Janahmadi, Mohammad Shabani
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Neuroscience
Subjects:
Online Access:https://doi.org/10.1186/s12868-023-00786-4
_version_ 1797865447292403712
author Hoda Ranjbar
Monavareh Soti
Kristi A. Kohlmeier
Mahyar Janahmadi
Mohammad Shabani
author_facet Hoda Ranjbar
Monavareh Soti
Kristi A. Kohlmeier
Mahyar Janahmadi
Mohammad Shabani
author_sort Hoda Ranjbar
collection DOAJ
description Highlights Purkinje cell excitability dramatically increased after exposure to 3-AP. 3-AP caused a significant decrease in ISI, half-width, and first spike latency. CB1R antagonist attenuated the cellular effects of 3-AP. AM251 reduced the excitability of Purkinje cells exposed to 3-AP.
first_indexed 2024-04-09T23:08:55Z
format Article
id doaj.art-0315faaf8e6643a4b49ed539772620e5
institution Directory Open Access Journal
issn 1471-2202
language English
last_indexed 2024-04-09T23:08:55Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Neuroscience
spelling doaj.art-0315faaf8e6643a4b49ed539772620e52023-03-22T10:31:11ZengBMCBMC Neuroscience1471-22022023-03-0124111110.1186/s12868-023-00786-4Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-APHoda Ranjbar0Monavareh Soti1Kristi A. Kohlmeier2Mahyar Janahmadi3Mohammad Shabani4Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical SciencesNeuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical SciencesDepartment of Drug Design and Pharmacology, Faculty of Health Sciences, University of CopenhagenDepartment of Physiology, School of Medicine, Shahid Beheshti University of Medical SciencesNeuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical SciencesHighlights Purkinje cell excitability dramatically increased after exposure to 3-AP. 3-AP caused a significant decrease in ISI, half-width, and first spike latency. CB1R antagonist attenuated the cellular effects of 3-AP. AM251 reduced the excitability of Purkinje cells exposed to 3-AP.https://doi.org/10.1186/s12868-023-00786-4AtaxiaCerebellumPurkinje cellCannabinoidCB1R
spellingShingle Hoda Ranjbar
Monavareh Soti
Kristi A. Kohlmeier
Mahyar Janahmadi
Mohammad Shabani
Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP
BMC Neuroscience
Ataxia
Cerebellum
Purkinje cell
Cannabinoid
CB1R
title Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP
title_full Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP
title_fullStr Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP
title_full_unstemmed Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP
title_short Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP
title_sort pharmacologic antagonism of cb1 receptors improves electrophysiological alterations in purkinje cells exposed to 3 ap
topic Ataxia
Cerebellum
Purkinje cell
Cannabinoid
CB1R
url https://doi.org/10.1186/s12868-023-00786-4
work_keys_str_mv AT hodaranjbar pharmacologicantagonismofcb1receptorsimproveselectrophysiologicalalterationsinpurkinjecellsexposedto3ap
AT monavarehsoti pharmacologicantagonismofcb1receptorsimproveselectrophysiologicalalterationsinpurkinjecellsexposedto3ap
AT kristiakohlmeier pharmacologicantagonismofcb1receptorsimproveselectrophysiologicalalterationsinpurkinjecellsexposedto3ap
AT mahyarjanahmadi pharmacologicantagonismofcb1receptorsimproveselectrophysiologicalalterationsinpurkinjecellsexposedto3ap
AT mohammadshabani pharmacologicantagonismofcb1receptorsimproveselectrophysiologicalalterationsinpurkinjecellsexposedto3ap